Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence

Overview of attention for article published in Frontiers in Cardiovascular Medicine, May 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 41 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,592 followers.

RT @GendronNico: 🚨 New oral anti-FXIa anticoagulant therapy 💊🩸 - MilveXIan - AsundeXIan 🗞@Cihan_Ay_MD ⤵️ https://t.co/6QmkZGi750

11 Oct 2022

Reply Repost Favourite

🚨 New oral anti-FXIa anticoagulant therapy 💊🩸 - MilveXIan - AsundeXIan 🗞@Cihan_Ay_MD ⤵️ https://t.co/6QmkZGi750

11 Oct 2022

Reply Repost Favourite

New Research: Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence: Although anticoagulation therapy has evolved from non-specific drugs (i.e., heparins and… https://t.co/1YLi

14 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.